Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128472) titled 'Investigating the translational potential of parthenolide for ameliorating non-alcoholic fatty liver disease (NAFLD) in obese adults' on July 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Hong Kong Polytechnic University
Condition:
Metabolic dysfunction-associated fatty liver disease
Intervention:
PNL group:Parthenolide (PNL) dietary supplementation
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2026-01-27
Target Sample Size: PNL group:60;Placebo group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...